HighMark Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.12K | Hold |
75
| – | – | ﹤0.01% | 419 |
|
|
2025
Q1 | $5.3K | Hold |
75
| – | – | ﹤0.01% | 366 |
|
|
2024
Q4 | $4.93K | Hold |
75
| – | – | ﹤0.01% | 384 |
|
|
2024
Q3 | $5.27K | Hold |
75
| – | – | ﹤0.01% | 395 |
|
|
2024
Q2 | $6.18K | Hold |
75
| – | – | ﹤0.01% | 355 |
|
|
2024
Q1 | $6.55K | Hold |
75
| – | – | ﹤0.01% | 347 |
|
|
2023
Q4 | $7.23K | Hold |
75
| – | – | 0.01% | 315 |
|
|
2023
Q3 | $6.64K | Sell |
75
-75
| -50% | -$6.64K | 0.01% | 314 |
|
|
2023
Q2 | $13K | Hold |
150
| – | – | 0.01% | 228 |
|
|
2023
Q1 | $14.6K | Hold |
150
| – | – | 0.01% | 244 |
|
|
2022
Q4 | $15.5K | Hold |
150
| – | – | 0.01% | 195 |
|
|
2022
Q3 | $13K | Hold |
150
| – | – | 0.01% | 200 |
|
|
2022
Q2 | $12K | Hold |
150
| – | – | 0.01% | 219 |
|
|
2022
Q1 | $12K | Hold |
150
| – | – | 0.01% | 235 |
|
|
2021
Q4 | $13K | Sell |
150
-152
| -50% | -$13.2K | 0.01% | 223 |
|
|
2021
Q3 | $23K | Buy |
+302
| New | +$23K | 0.02% | 170 |
|
|
2020
Q3 | – | Sell |
-69
| Closed | -$9K | – | 447 |
|
|
2020
Q2 | $9K | Buy |
+69
| New | +$9K | 0.01% | 212 |
|